Drugs / Anti-thyroglobulin mTCR-transduced Autologous Peripheral Blood Lymphocytes
Anti-thyroglobulin mTCR-transduced Autologous Peripheral Blood Lymphocytes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02774291 | Apr 2017 → Jul 2020 | metastatic malignant neoplasm in the brain | Albert Einstein College of Medicine | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-thyroglobulin mTCR-transduced Autologous Peripheral Blood Lymphocytes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02774291 ↗ |